The first thing a child psychiatrist learns is that children are not small adults.
That distinction seems obvious. In utilization management, it’s often ignored.
Rates of anxiety, depression, and behavioral disorders among children and adolescents have reached crisis levels, driving an unparalleled demand for care. Health plans are facing pressure to build efficient, integrated care models that move cases faster and reduce administrative burden.
Behavioral health is no exception to this pressure; however, pediatric psychiatry presents a specific and underappreciated strain. Developmental context, family systems, school and social factors, and medication protocols that don’t mirror adult standards aren’t edge cases. They’re the clinical reality of nearly every case in this population. Reviewing these cases requires more than operational efficiency. It requires subspecialty depth.
For most health plans, that depth is exactly what’s missing. In utilization management, subspecialty expertise in child and adolescent psychiatry isn’t an afterthought. It’s a clinical and operational imperative.
The Exponential Demand for Child and Adolescent Psychiatric Care
The scale of the problem is no longer debatable. In 2023, roughly 1 in 5 adolescents ages 12 to 17 had a current, diagnosed mental or behavioral health condition. Between 2016 and 2023, the prevalence of diagnosed mental or behavioral health conditions among adolescents increased by 35%, with diagnosed anxiety up by 61% and depression up by 45%. These aren’t post-pandemic anomalies. They’re a structural shift in the behavioral health needs of an entire generation.
Health plans, third-party administrators, and employers need to adjust to this shift in real time.
Among adolescents with a current diagnosis who needed treatment, 61% reported difficulty accessing it in 2023, a 35% increase since 2018. When the system can’t absorb that demand in outpatient settings, cases escalate into inpatient admissions, residential placements, partial hospitalization, and intensive outpatient requests, each requiring clinical review. Every gap in the community safety net becomes a case in a utilization queue.
Here’s what makes it harder than it looks on paper: A 13-year-old presenting with acute anxiety requires a different clinical lens than an adult with the same diagnosis. It needs to account for family dynamics, school environment, trauma history, and medication considerations that aren’t identical to adult protocols. The clinical variables are different, as are the level-of-care thresholds. The stakes are even higher because the downstream effects of a wrong review for a child in formative developmental years can be consequential.
Why Pediatric Psychiatric Cases Present Unique Review Challenges
Pediatric psychiatric cases are uniquely complex. A 15-year-old presenting with severe depression may also carry a trauma history, a learning disability, and a home environment that is actively destabilizing her recovery. Comorbidity is the norm in this population, and untangling it requires a reviewer who understands how these conditions interact developmentally.
The wide spectrum of cases reflects this complexity:
- Inpatient psychiatric admissions for suicidal ideation or suicide attempts
- Residential treatment center placements for youth with chronic behavioral or trauma-related conditions
- Partial hospitalization and intensive outpatient requests following acute episodes
- Extended stays beyond initial authorization, where continued stay criteria are particularly difficult to apply in adolescents
- Concurrent medical and psychiatric admissions requiring coordination across service lines
- Medication management reviews: Prior authorization for atypical antipsychotics, stimulants, mood stabilizers, and other psychotropics in pediatric populations, where dosing, off-label use, and developmental appropriateness add complexity
- Autism spectrum disorder (ASD) and co-occurring conditions: ABA therapy authorizations, as well as reviews involving ADHD, anxiety, mood disorders, and trauma presenting alongside ASD
- Eating disorders: Anorexia, bulimia, and ARFID in adolescents often require multi-setting review across medical and psychiatric levels of care, where medical necessity criteria can be difficult to apply without subspecialty knowledge
- Substance use and dual diagnosis: Reviews involving co-occurring substance use and psychiatric conditions, where treatment setting and duration decisions are especially high-stakes
- Extended or repeated acute episodes: Cases involving frequent readmissions or chronic high utilization that require clinical pattern recognition beyond standard criteria application
Creating the Capacity for Subspecialty Review
Generalist reviewers are skilled clinicians. The problem isn’t effort — it’s fit. Reviewing child and adolescent psychiatric cases requires a clinical frame that general behavioral health training doesn’t reliably provide.
When that fit is missing, the consequences are predictable: criteria applied technically but not clinically, denials that don’t hold up under challenge, peer-to-peer conversations that go poorly, and appeals that carry real costs in administrative time, legal exposure, and regulatory risk as federal and state parity enforcement has intensified.
The obvious solution is to build this capacity internally, but today’s workforce doesn’t support it. Child and adolescent psychiatrists are among the scarcest specialists in medicine, with severe shortages across the country. For most health plans, leveraging a credentialed subspecialty review partner is a viable option to filling that gap in expertise.
What to Look for in a Behavioral Health UM Partner
Not all review organizations are equipped for this population. When evaluating a partner, four criteria matter most:
- A credentialed panel of child and adolescent psychiatrists. Board certification in child and adolescent psychiatry is a distinct credential, earned through additional training beyond general psychiatry.
- Familiarity with pediatric-specific criteria. InterQual, MCG, and similar tools have pediatric modules, but applying them correctly requires clinical experience with this population, not just access to the tool. Ask how reviewers are trained on pediatric criteria and how that training is maintained.
- Subspecialty peer-to-peer capability. When decisions are challenged, peer-to-peer conversations matter. That conversation should happen between clinical equals as the standard for producing defensible outcomes and supporting the treating relationship.
- Turnaround times that don’t sacrifice rigor. Pediatric psychiatric cases, especially those involving acute safety concerns, require both speed and clinical depth. In the hands of an experienced subspecialty reviewer, these aren’t competing priorities.
Matching Review Expertise to the Complexity of the Case
The regulatory and operational pressure on health plans to get behavioral health reviews right the first time, every time is only intensifying.
Subspecialty expertise in child and adolescent psychiatry isn’t a feature to evaluate during the next contract cycle. It’s a gap that’s costing plans right now in appeals, in peer-to-peer losses, in regulatory exposure, and in outcomes for a population that has very little margin for error.
MRIoA’s panel of board-certified child and adolescent psychiatrists brings the subspecialty depth that pediatric psychiatric UM demands with the turnaround times, peer-to-peer capability, and criteria expertise to support defensible, clinically grounded decisions at every level of care.
